Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma

doi:10.3748/wjg.v21.i42.12022

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (15132)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

1330

WORD

464

HTML

10553

Figures (1-3)

154

Tables (1-2)

175

Sum=12676

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1139

Download

1317

Sum=2456

Nov 14, 2015 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 14, 2015; 21(42): 12022-12041
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12022

Full Size Figure Download Figure

Figure 3 Schematic representation of the biotinylated cyclic Arg-Gly-Asp nanoparticles loaded with doxorubicin. PEG: Polyethylene glycol; RGD: Arg-Gly-Asp.

Citation: Varshosaz J, Farzan M. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12022-12041
URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12022.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12022